Understanding TCR and PDZ: Structure, Function and Potential Drug Targets/Biomarkers

Target Name: gamma-delta T Cell Receptor (TCR) Complex

NCBI ID: P23188

Other Name(s): gamma-delta TCR complex | gamma-delta T-cell receptor complex | gamma-delta T-lymphocyte receptor complex | gamma-delta T lymphocyte receptor complex

Understanding TCR and PDZ: Structure, Function and Potential Drug Targets/Biomarkers

The gamma-delta T cell receptor (TCR) complex is a protein that plays a crucial role in regulating immune responses. It is a complex of two key proteins, T-cell antigen recognition receptor tyrosine kinase (TCR) and thymine Acid dimer transducerase (PDZ). This article will explore the role, structure, and function of this molecule, as well as its potential as a drug target or biomarker.

1. Structure

TCR and PDZ are dimers composed of two subunits that share an extracellular region, called the extracellular region or CDR region. This region includes one alpha chain and two beta chains. The 伪 chain of TCR includes one CDR and two 伪 helices, while the 伪 chain of PDZ includes one 伪 helix and one 尾 chain. These two subunits are linked together through non-covalent interactions to form a tight complex.

2. Function

The combination of TCR and PDZ is critical for the regulation of cellular immune responses. In TCR signaling, PDZ transmits extracellular signals into cells by binding to the CDR on the 伪 chain of TCR. This signal transduction pathway involves multiple steps, including the binding of PDZ to TCR, the binding of PDZ to intracellular receptors, and phosphorylation. These steps enable cells to detect the antigen and initiate an intracellular immune response.

The role of PDZ in TCR signaling is also reflected in regulating the activity and diversity of TCR. Studies have shown that PDZ can phosphorylate TCR, thereby increasing TCR activity. In addition, PDZ can also affect the processing and degradation of TCR and regulate the stability of TCR.

3. Potential as drug target or biomarker

Due to their important roles in immune responses, TCR and PDZ are widely regarded as drug targets or biomarkers. Currently, a variety of drugs are being studied, aiming to modulate the functions of TCR and PDZ to treat various immune-related diseases.

1. Drug targets

(1) PDZ

PDZ can be used as a drug target to treat a variety of immune-related diseases. For example, PDZ can be used to treat autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus, etc. In addition, PDZ can also be used to treat cancer, such as melanoma.

(2)TCR

TCR and its ligands (such as TCR agonists) can be used as drug targets to treat various cancers. For example, PDZ can be combined with anti-PDZ antibodies to treat skin cancer. In addition, TCR agonists can also be used to treat autoimmune diseases, such as lupus erythematosus.

2. Biomarkers

TCR and PDZ can be used as biomarkers to detect immune system function and inflammatory status. For example, PDZ can be used to detect the immune status of colon cancer patients to assess the effectiveness of immunotherapy. In addition, TCR can be used to detect the functional status of T cells to assess the overall function of the immune system.

Conclusion

TCR and PDZ are important molecules that play an important role in cellular immune responses. They can be used as drug targets or biomarkers to treat a variety of immune-related diseases. Future research will continue to further explore the functions of TCR and PDZ and explore their potential in treating immune-related diseases.

Protein Name: Gamma-delta T Cell Receptor (TCR) Complex

More Common Targets